Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act FDA
But the benefits go far beyond that
Established adipose tissue as a primary target organ for NNMT-inhibition research
Freeze-thaw sensitivity is lower than for a peptide, since there is no secondary structure to lose, but aliquoting still avoids repeated stopper punctures and concentration drift from evaporation
It is not FDA-approved for the treatment, prevention, or cure of any disease
Gastroenterology 2012;142:505-512.e1
US$ 26.46
US$ 28.97
US$ 24.37
US$ 20.23
